Those with Type 2 Diabetes Have a 50% Greater Risk of Dementia

Conclusion In diabetic patients those initiating metformin had a five year reduced risk of dementia in comparison to patients initiating other therapies. Animal models suggest metformin may contribute to neurogenesis and trials are evaluating metformin as a potential therapeutic for mild cognitive impairment. These results are preliminary evidence that benefits of insulin sensitizers may extend beyond glycemic control to neurocognitive health. Related Content What is the Difference Between Alzheimer’s and Dementia Test Your Memory for Alzheimer's (5 Best Tests) How to Reduce Memory Loss Is Alzheimer's World an Irrational Place? Communicating in Alzheimer's World The Seven Stages of Alzheimer's To learn more about Alzheimer's and Dementia visit the Alzheimer's Reading Room.
Source: Alzheimer's Reading Room, The - Category: Dementia Authors: Source Type: blogs